From a molecular therapeutic viewpoint, Relafen 750 (Naproxen Sodium) embodies a powerful illustration of noncopyrightal anti-inflammatory agent. Its mechanism revolves around blocking cyclooxygenase catalysts , specifically COX-1 and COX-2, thereby reducing the production of prostaglandins, which are central instigators of pain and swelling . R… Read More